Evaluating COVID-19 Vaccine Willingness and Hesitancy among Parents of Children Aged 5-11 Years with Chronic Conditions in Italy.

COVID-19 Italy children chronic condition hesitancy parents vaccination

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
04 Mar 2022
Historique:
received: 31 01 2022
revised: 24 02 2022
accepted: 01 03 2022
entrez: 26 3 2022
pubmed: 27 3 2022
medline: 27 3 2022
Statut: epublish

Résumé

COVID-19 vaccination has been extended to include children aged 5-11 years. This cross-sectional survey evaluated parental COVID-19 vaccine willingness and hesitancy, and associated factors, for their children aged 5-11 years with chronic conditions. A telephone survey was conducted from 14 December 2021 to 4 January 2022. The questionnaire assessed participants' socio-demographic and health-related information, attitudes towards COVID-19 infection, hesitancy, by using the PACV-5 (Parent Attitudes About Childhood Vaccines Survey Tool), and sources of information. A total of 430 answers were collected anonymously. Respondents with no cohabitant who had been infected by SARS-CoV-2 and having been vaccinated against COVID-19 had a higher concern about the severity of COVID-19. The parents' perceived risk that the child could be infected by SARS-CoV-2 was higher in those more concerned about the severity of COVID-19, with an older child, and who had at least one cohabitant positive for COVID-19. Only 38.8% parents were willing to vaccinate their children against COVID-19. Parents who did not need additional information, those with higher education, those who have been vaccinated against COVID-19, those whose child was older, who had received information on this vaccination from physicians, with higher self-reported concern about the severity of COVID-19, and who had a higher perceived risk that their child could be infected by SARS-CoV-2, expressed a greater willingness to vaccinate their child. Overall, 26.3% were high-hesitant, with a PACV-5 score ≥ 7. Respondents who did not get the COVID-19 vaccine, were less educated, with a lower concern about severity of COVID-19, and with a lower perceived risk that their child could be infected by SARS-CoV-2, were more likely to be high-hesitant. New policies and educational programs regarding COVID-19 vaccination for children with chronic conditions are needed to reduce hesitancy and increase vaccination uptake.

Identifiants

pubmed: 35335028
pii: vaccines10030396
doi: 10.3390/vaccines10030396
pmc: PMC8953590
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Regione Campania
ID : Executive decree n.75/2017 Strategic and nationally relevance objectives indicated in the National Health Plan. FSN 2014, 2015, 2016

Références

Vaccine. 2022 Jan 21;40(2):213-222
pubmed: 34895784
Vaccines (Basel). 2021 Jan 19;9(1):
pubmed: 33477779
Front Public Health. 2021 Nov 05;9:779720
pubmed: 34805084
Expert Rev Vaccines. 2022 Apr;21(4):541-547
pubmed: 34949136
Hum Vaccin Immunother. 2021 Nov 2;17(11):3969-3974
pubmed: 34344258
Vaccine. 2021 Jun 16;39(27):3602-3607
pubmed: 34034950
Vaccine. 2016 Sep 22;34(41):4964-4968
pubmed: 27566902
Hum Vaccin Immunother. 2021 Dec 2;17(12):5076-5081
pubmed: 34715004
Lancet Oncol. 2021 Oct;22(10):1416-1426
pubmed: 34454651
Vaccine. 2021 Dec 20;39(52):7669-7676
pubmed: 34688500
J Affect Disord. 2022 Feb 15;299:196-204
pubmed: 34875283
Vaccine. 2022 Jan 24;40(3):494-502
pubmed: 34906392
PLoS One. 2021 Dec 17;16(12):e0261121
pubmed: 34919580
Hum Vaccin Immunother. 2021 Dec 2;17(12):4993-4998
pubmed: 34623937
Front Public Health. 2021 Oct 27;9:725980
pubmed: 34778168
Clin Ther. 2022 Jan;44(1):e1-e10
pubmed: 34865871
Eur J Pediatr. 2021 Nov;180(11):3405-3410
pubmed: 33999257
Hum Vaccin Immunother. 2020 Nov 1;16(11):2744-2751
pubmed: 32298210
BMC Public Health. 2021 Sep 26;21(1):1759
pubmed: 34565351
Vaccine. 2021 Dec 3;39(49):7140-7145
pubmed: 34763947
Vaccines (Basel). 2021 Sep 02;9(9):
pubmed: 34579219
Pediatrics. 2021 Oct;148(4):
pubmed: 34344800
Vaccines (Basel). 2022 Jan 19;10(2):
pubmed: 35214605
Pediatrics. 2021 Dec 22;:
pubmed: 34935038
Vaccine. 2021 Jul 30;39(33):4716-4722
pubmed: 34119349
Expert Rev Vaccines. 2022 Mar;21(3):385-395
pubmed: 34974779
Front Public Health. 2020 Jul 14;8:381
pubmed: 32760691
Vaccine. 2022 Jan 3;40(1):151-161
pubmed: 34863621
Front Immunol. 2021 Nov 29;12:781161
pubmed: 34912346
Vaccines (Basel). 2021 Apr 10;9(4):
pubmed: 33920109
J Med Internet Res. 2021 Jan 20;23(1):e17187
pubmed: 33470931
JMIR Public Health Surveill. 2021 Nov 9;7(11):e31707
pubmed: 34653014
Vaccines (Basel). 2021 Jun 10;9(6):
pubmed: 34200656
Hum Vaccin Immunother. 2021 Oct 3;17(10):3322-3332
pubmed: 34137670
Vaccine. 2022 Jan 3;40(1):43-51
pubmed: 34857421
Vaccines (Basel). 2021 Sep 30;9(10):
pubmed: 34696223
Expert Rev Vaccines. 2021 Jul;20(7):881-889
pubmed: 33900148
Vaccines (Basel). 2021 Oct 04;9(10):
pubmed: 34696242
J Infect Public Health. 2021 Oct;14(10):1489-1496
pubmed: 34417135
Vaccines (Basel). 2021 Jan 14;9(1):
pubmed: 33466675
Hum Vaccin Immunother. 2020 May 3;16(5):1070-1077
pubmed: 32017643
Eur J Epidemiol. 2021 Feb;36(2):197-211
pubmed: 33649879
Front Public Health. 2021 Jul 26;9:614499
pubmed: 34381748
Int J Environ Res Public Health. 2019 Jun 12;16(12):
pubmed: 31212739
Int J Environ Res Public Health. 2020 Jul 27;17(15):
pubmed: 32727024
Vaccines (Basel). 2021 Mar 18;9(3):
pubmed: 33803730
Vaccines (Basel). 2021 Nov 24;9(12):
pubmed: 34960137
Vaccines (Basel). 2020 Sep 25;8(4):
pubmed: 32992864
Front Immunol. 2021 Jun 14;12:558270
pubmed: 34194418
Vaccines (Basel). 2021 Nov 03;9(11):
pubmed: 34835207
J Infect Public Health. 2021 Oct;14(10):1497-1504
pubmed: 34481723
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-9
pubmed: 34752716

Auteurs

Grazia Miraglia Del Giudice (G)

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Via Luciano Armanni 5, 80138 Naples, Italy.

Annalisa Napoli (A)

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Via Luciano Armanni 5, 80138 Naples, Italy.

Francesco Corea (F)

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Via Luciano Armanni 5, 80138 Naples, Italy.

Lucio Folcarelli (L)

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Via Luciano Armanni 5, 80138 Naples, Italy.

Italo Francesco Angelillo (IF)

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Via Luciano Armanni 5, 80138 Naples, Italy.
Department of Public Health and Laboratory Services, Teaching Hospital of the University of Campania "Luigi Vanvitelli", Via Luciano Armanni 5, 80138 Naples, Italy.

Classifications MeSH